Technologies Available for Licensing

For Licensing Opportunities, please contact the ORTA at


An inactivated dengue virus vaccine to immunize and protect humans against dengue fever is described. The vaccine is based on dengue viruses which have been propagated to high titers in suitable cells, purified and inactivated under conditions which destroy infectivity but preserve immunogenicity, a high level of which is demonstrated in animal models.

Docket:WRAIR 95-02

Publication/Issued No.:6,254,873

Publication/Issue Date:2001-07-03

Categories: Vaccine

More Detail:Visit USPTO.GOVExternal link


Inventor(s):PUTNAK, J.; ECKELS, K.; DUBOIS, D.

For Licensing Opportunities, please contact the ORTA at

Last Modified Date: 25 Jul 2023

This Web site provides an introduction to the Office of Research and Technology Applications (ORTA) and contains official Government information.

Its use is intended for members of the general public, news media and Military Health System beneficiaries.

Please address questions or concerns about this Web site to the USAMRDC Public Affairs Office at: or by telephone at (301)619-2736.